2024-519640-32-00已完成4 期
Multiple-Dose Study on the Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diaprel® MR) in Healthy Participants under Fed Conditions.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Studies Department
Scientific
Institut De Recherches Internationales Servier IRIS
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Bioequivalence study of single dose, two-way crossover design with two-period, two-treatment of Octreotide-SBS 100 mcg/mL subcutaneous injection relative to Sandostatin®Healthy VolunteersTCTR20180920004Siam Bioscience28
尚未招募
1 期
A Bioequivalence study of a multiple dose (steady state) randomized, open-label, two-way crossover design with two-period, two-treatment and two-sequence between Venlafaxine Prolonged -release Capsules BP 150 mg in healthy Thai volunteers under fed conditioHealthy subjectsBioequivalence Venlafaxine Prolonged-release Capsules BP 150 mgTCTR20240427014Bio-innova Co., Ltd.32
已完成
4 期
A Single Dose, Fast State, Bioequivalence Study of CEFIXIMA ATB 400 mg Hard Capsules (Antibiotice S.A.) vs. CEFIXORAL® 400 mg Film Coated Tablets (A. Menarini Industrie Farmaceutiche Riunite s.r.l.)2023-504011-33-00Antibiotice S.A.28
已完成
1 期
A Study to Investigate Single Ascending Doses of Ocrelizumab for Safety and Side Effects, How The Body Handles It Over A Period of Time, How The Body Notices and Reacts To It, And Its Effect On The Body When Given As A Subcutaneous Injection In Patients With Multiple Sclerosis2024-513639-26-00F. Hoffmann-La Roche AG44
尚未招募
1 期
Single-Dose, Fed Bioequivalence study of Mylan Esomeprazole 40 mg DR tablets; Mylan Laboratories Limited, India relative to Nexium® 40 mg tablets of AstraZeneca in healthy Thai volunteersBioequivalence studyEsomeprazoleTCTR20200630001Bio-innova and Synchron.Co.,Ltd48